Shilong Fu

ORCID: 0000-0001-7416-3070 · 4 papers in corpus
article 2010
Clinical outcomes of levonorgestrel-releasing intrauterine system in treating adenomyosis

Objective To evaluate the efficacy of levonorgestrel-releasing intrauterine system(LNG-IUS) in the treatment of adenomyosis.Methods LNG-IUS was inserted into uterine cavity in 44 women with adenomyosis.The patients were followed up for 12 m…

article 2009
Ectopic, autologous eutopic and normal endometrial stromal cells have altered expression and chemotactic activity of RANTES
European journal of obstetrics, gynecology, and reproductive biology ·doi:10.1016/j.ejogrb.2008.12.001

ObjectiveTo evaluate if the expression and chemotactic activity of RANTES are different in IL-1beta treated autologous eutopic endometrial stromal cells compared to ectopic and normal endometrium.Study designConditioned media from IL-1beta-…

article 2009
ERB-041, a selective ERβ agonist, inhibits iNOS production in LPS-activated peritoneal macrophages of endometriosis via suppression of NF-κB activation
Molecular immunology ·doi:10.1016/j.molimm.2009.04.014

ObjectiveThe aim of the present study was to assess the anti-inflammatory effects of selective ER beta (ER beta) agonist on lipopolysaccharide (LPS)-induced inducible nitric oxide synthase (iNOS) production in peritoneal macrophages (PMs) o…

article 2009
NF-κB Decoy Oligonucleotides Suppress RANTES Expression and Monocyte Chemotactic Activity via NF-κB Inactivation in Stromal Cells of Ectopic Endometrium
Journal of clinical immunology ·doi:10.1007/s10875-009-9274-z

BackgroundThe nuclear factor kappa B (NF-kappaB) pathway is a critical mediator of regulated on activation, normal T cell expressed and secreted (RANTES) gene regulation and therefore represents a potential target for therapy of endometrios…